The HIH, with the participation of research group leader Prof. Matthis Synofzik, will contribute to the development of new study endpoints and statistical analysis models that are needed to measure therapy effects.

Read the press release from the University Hospital Tübingen here (in German)

Prof. Matthis Synofzik